Publications by authors named "Michael Loken"

Claim this Profile
A
A Case of Blinatumomab Efficacy in RAM Immunophenotype/CBFA2T3::GLIS2 Fusion AML.
Maya Ball-Burack, Andrew Menssen, Lisa Eidenschink Brodersen, Arun Nalla, Michael Loken

Pediatr Blood Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence and Implications of DNMT3A Mutations in Pediatric AML Post-HSCT: A Case Report and Literature Review.
Aarushi Madan, Amitesh Anerao, Danielle Mucker, Caitlin Giovanetti, Jamie Frediani, Michael R Loken

Pediatr Blood Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual Disease.
Jason N Berman, Anupam Verma, Shelton A Viola, Todd Alonzo, Yi-Cheng Wang, Michael R Loken

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.
Curtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena, Emmanuelle Tavernier-Tardy, Fangyan Dai, Michael R Loken

Blood Cancer Discov· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group.
Benjamin J Huang, Lauren K Meyer, Todd A Alonzo, Yi-Cheng Wang, Adam J Lamble, Michael R Loken

J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group.
Benjamin J Huang, Lauren K Meyer, Todd A Alonzo, Yi-Cheng Wang, Adam J Lamble, Michael R Loken

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitoxantrone in combination with clofarabine (MITCL) in children, adolescents and young adults with relapsed/refractory acute leukaemia: final results of a phase I/II trial.
Jessica Hochberg, Javier Oesterheld, Aliza Gardenswartz, Allyson Flower, Liana Klejmont, Michael R Loken

EClinicalMedicine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response.
Meagan A Jacoby, Eric D Duncavage, Ajay Khanna, Gue Su Chang, Sridhar Nonavinkere Srivatsan, Michael R Loken

Leukemia· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine-mediated CAR T therapy resistance in AML.
Anand S Bhagwat, Leonel Torres, Olga Shestova, Maksim Shestov, Patrick W Mellors, Michael R Loken

Nat Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children's Oncology Group.
Andrew J Menssen, Chad A Hudson, Todd Alonzo, Robert Gerbing, Laura Pardo, Michael R Loken

Haematologica· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusion-harboring mast cells can explain molecular positivity in flow cytometric MRD-negative core-binding factor AML.
Jacqueline A Cook, Loren Lott, Jenna Perry, Ashley M Eckel, Dongbin Xu, Michael R Loken

Blood· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target.
Quy Le, Brandon Hadland, Jenny L Smith, Amanda Leonti, Benjamin J Huang, Michael R Loken

J Clin Invest· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring response to therapy in AML: Difference from normal flow cytometry vs RQ-PCR.
Michael R Loken, Chad A Hudson

Methods Cell Biol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor College of Medicine.
Alexandra M Stevens, Maci Terrell, Raushan Rashid, Kevin E Fisher, Andrea N Marcogliese, Michael Loken

Biomedicines· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A longitudinal single-cell atlas of treatment response in pediatric AML.
Sander Lambo, Diane L Trinh, Rhonda E Ries, Dan Jin, Audi Setiadi, Michael R Loken

Cancer Cell· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive molecular and clinical characterization of fusions in pediatric acute myeloid leukemia.
Eline J M Bertrums, Jenny L Smith, Lauren Harmon, Rhonda E Ries, Yi-Cheng J Wang, Michael R Loken

Haematologica· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of Down syndrome-specific non-malignant hematopoietic regeneration in the bone marrow on the detection of leukemic measurable residual disease.
Fan-Chi Hsu, Chad Hudson, Elisabeth R Wilson, Laura M Pardo, Timothy P Singleton, Michael R Loken

Cytometry B Clin Cytom· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia.
Quy Le, Thao Tang, Amanda Leonti, Sommer Castro, Cyd Nourigat McKay, Michael R Loken

Blood Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targeting of PRAME with mTCRCAR T cells in acute myeloid leukemia.
Danielle C Kirkey, Anisha M Loeb, Sommer Castro, Cyd Nourigat McKay, LaKeisha Perkins, Michael R Loken

Blood Adv· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
Anna Porwit, Marie C Béné, Carolien Duetz, Sergio Matarraz, Uta Oelschlaegel, Michael R Loken

Cytometry B Clin Cytom· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target.
Quy Le, Brandon Hadland, Jenny L Smith, Amanda Leonti, Benjamin J Huang, Michael R Loken

J Clin Invest· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1-antibody-drug conjugate.
Thao Tang, Quy Le, Sommer Castro, Laura Pardo, Cyd Nourigat McKay, Michael R Loken

Blood Adv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio /ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031.
Jessica A Pollard, Todd A Alonzo, Robert Gerbing, Patrick Brown, Elizabeth Fox, Michael R Loken

J Clin Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia with an fusion in a young child with Down syndrome.
Jaclyn Rosenzweig, Pallavi M Pillai, Susan Prockop, Ryma Benayed, Lisa Eidenschink Brodersen, Michael R Loken

Cold Spring Harb Mol Case Stud· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict Survival.
Lauren Pommert, Todd M Cooper, Robert B Gerbing, Lisa Brodersen, Michael Loken

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis